When we first tried to get a prescription for Galliprant it was a challenge in our remote location in upstate NY.
Nobody knew anything about the drug and we could only buy it mail order with prescription. The dog was a pitiful basket case and a routine drug was generally useless with enormous pain continuing from arthritis.
My wife just got back with glowing reports from a mandatory check up, news other dogs were now on the drug and doing great as well.
Eli Lilly is now pushing the drug offshore as well as in the U.S.
I expect at least the marketing of Galliprant to be sweet reading in the future and hardly the only arrow in PETX's quiver.
We all know the finances are - difficult - and I am personally appalled by the "help" from an "activist fund" but I have my rose-colored glasses firmly in place.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.